Dr. Keri Maher
Claim this profileVirginia Commonwealth University/Massey Cancer Center
Expert in Leukemia
Studies Acute Myeloid Leukemia
17 reported clinical trials
44 drugs studied
Area of expertise
1Leukemia
Global LeaderTP53 positive
BCR-ABL1 positive
CD22 positive
2Acute Myeloid Leukemia
TP53 positive
FLT3 positive
Stage I
Affiliated Hospitals
Clinical Trials Keri Maher is currently running
Venetoclax + ASTX727
for Chronic Myelomonocytic Leukemia
This trial is testing if a combination of two drugs, ASTX727 and venetoclax, is more effective than ASTX727 alone in treating certain bone marrow cancers. It focuses on patients with CMML and MDS/MPN who have too many immature blood cells. ASTX727 helps produce normal blood cells and kills abnormal ones, while venetoclax blocks a protein that cancer cells need to survive. Venetoclax is an anticancer drug used to treat lymphomas and leukemias, but it has severe side effects.
Recruiting1 award Phase 2
Inotuzumab Ozogamicin + Chemotherapy
for Leukemia and Lymphoma
This trial tests a new treatment combining inotuzumab ozogamicin with chemotherapy for patients with certain types of blood cancer. The new drug targets cancer cells directly and delivers a toxin to kill them. This approach aims to improve the effectiveness of treatment compared to standard chemotherapy alone. Inotuzumab ozogamicin has shown superior efficacy compared to conventional chemotherapy in patients with specific types of blood cancer.
Recruiting3 awards Phase 2
More about Keri Maher
Clinical Trial Related1 year of experience running clinical trials · Led 17 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Keri Maher has experience with
- Cytarabine
- Inotuzumab Ozogamicin
- Daunorubicin Hydrochloride
- Venetoclax
- Selinexor
- Pevonedistat
Breakdown of trials Keri Maher has run
Leukemia
Acute Myeloid Leukemia
Myeloid Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Keri Maher specialize in?
Keri Maher focuses on Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Leukemia has involved TP53 positive patients, or patients who are BCR-ABL1 positive.
Is Keri Maher currently recruiting for clinical trials?
Yes, Keri Maher is currently recruiting for 9 clinical trials in Richmond Virginia. If you're interested in participating, you should apply.
Are there any treatments that Keri Maher has studied deeply?
Yes, Keri Maher has studied treatments such as Cytarabine, Inotuzumab Ozogamicin, Daunorubicin Hydrochloride.
What is the best way to schedule an appointment with Keri Maher?
Apply for one of the trials that Keri Maher is conducting.
What is the office address of Keri Maher?
The office of Keri Maher is located at: Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia 23298 United States. This is the address for their practice at the Virginia Commonwealth University/Massey Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.